L-Tyrosine Supplementation in Patients With Fibromyalgia

Stopped early · Not applicable · Has a placebo group

Conditions studied: Fibromyalgia

In brief

Patients in the study, who have a diagnosis of fibromyalgia, will be randomly assigned to take the amino acid L-tyrosine or placebo (blank pill) for 3 weeks. They will fill out questionnaires about their symptoms and see if they have any improvement. The investigators hypothesis is that taking tyrosine will help alleviate the symptoms of fibromyalgia.

Key facts

Study ID

NCT01219049

Run by

Icahn School of Medicine at Mount Sinai

People needed

15

Starts

2010-01-01

Expected to finish

2011-01-01

Last updated by the study team

2017-04-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of fibromyalgia
• Pain greater than 4/10
• Age greater than 18

You may not qualify if…

• Pregnant
• Age less than 18

Where it is running

• Mount Sinai School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.